| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d12fcf94a35348198bf31558dcff2cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_203bed9f5c9d709f7123f0f68fdee462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e03b98c3fd717a3d9b5136cb13fc2fa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7107bbfb034c629e522b7ca25ebfecb3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2012-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02514abfeae7c6cd2afbc1c54c5ce5fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a08f1b4f1a598c7b825988e8b631a58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b0f4baee1834985f325fbced18a6e4 |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012122228-A2 |
| titleOfInvention |
Biomarkers of chronic obstructive pulmonary disease |
| abstract |
The methods described herein are based on the discovery that the plasma level of a panel of specific proteins differs between two subject populations: 1) subjects at risk for chronic obstructive pulmonary disease ("COPD") but not manifesting clinical symptoms of COPD; and 2) subjects having very severe COPD. The difference in plasma levels is statistically significant for each protein. The identification of these proteins thus facilitates susceptibility detection, early disease detection, disease severity assessment, disease progression monitoring, and therapy efficacy monitoring. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9423403-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104812913-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2935334-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014074682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020081866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104812913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9103837-B2 |
| priorityDate |
2011-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |